Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > As Spectral seems to have no regard for IR/ PR..
View:
Post by hmmmmmmmm on Apr 18, 2022 4:43pm

As Spectral seems to have no regard for IR/ PR..

I'll post this video of Sepsis experts Jean-Louis Vincent and Richard Ferrer discussing PMX and endotoxin (and COVID19 use)

starts around min 5:30


https://www.youtube.com/watch?v=7JslkECJJ3M
Comment by oilandgasman on Apr 18, 2022 11:41pm
Comment by Stocktree on Apr 19, 2022 9:28am
Wow, great news! In particular: Vincent - But you will say that purification techniques have a good future in the field of sepsis? Ferrer - Well, I think it’s part of the support we have, so we should consider that for certain patients that have specific conditions that can be treated using endotoxin removal devices. Yes, we have to select the patients. I guess we are all set! Here the link ...more  
Comment by mercedesman on Apr 19, 2022 9:43am
It's almost as if JLV was an investor in Spectral. For years he has been comlaining about the almost impossible mortality benefit hurdle in RCT of purification products like PMX-B. (Aside: it sounds like Spectral may finally be "exceeding" those hurdles). And who could have known (as these two experts publicly agree) that Covid can lead to gut translocation and elevated Endotoxins ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities